Helicobacter pylori strain B23+S27R2:R48

Helicobacter pylori strain B23+S27R2:R48 is a microaerophilic, Gram-negative bacterium characterized by its spirilla shape and presence of flagella, which facilitates its movement in host-associated environments. This strain is notable for its singular replicon and double membrane structure, typical of many bacteria in its class. It thrives optimally at 37°C, placing it in the mesophilic temperature range. This bacterium is primarily associated with various hosts, including Homo sapiens (humans), Gallus gallus (chickens), Aves (birds), Primates, Mammalia, Amoeba, Rodentia, and Cricetinae. It is predominantly free-living but is recognized for its significant pathogenic potential in humans, contributing to a range of gastrointestinal diseases. Health effects linked to H. pylori strain B23+S27R2:R48 include chronic gastric inflammation, various forms of gastric cancer, gastric ulcers, and other gastrointestinal disorders such as functional dyspepsia and GERD. The strain's association with serious conditions like gastric adenocarcinoma and MALT lymphoma highlights its role in chronic infections and cancer development. Its ability to induce asymptomatic mucosal inflammatory responses suggests a complex interaction with host immune systems, where it may persist without immediate symptoms, complicating diagnosis and treatment. Understanding the pathogenicity of H. pylori strain B23+S27R2:R48 is crucial in addressing its health impacts and managing related diseases effectively.